DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Director Purchases $254,150.00 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) Director Randall Michael Giuffre acquired 65,000 shares of DiaMedica Therapeutics stock in a transaction that occurred on Friday, June 23rd. The shares were bought at an average price of $3.91 per share, with a total value of $254,150.00. Following the transaction, the director now directly owns 360,355 shares […]

Related Keywords

Randall Michael Giuffre ,Diamedica Therapeutics Company Profile ,Renaissance Technologies ,Dimensional Fund Advisors ,Nasdaq ,Catalyst Financial Partners ,Diamedica Therapeutics Inc ,Citadel Advisors ,Diamedica Therapeutics ,Get Rating ,Director Randall Michael Giuffre ,Medica Therapeutics ,Street Group ,Financial Partners ,Fund Advisors ,Medica Therapeutics Inc ,Diamedica Therapeutics Daily ,Nasdaq Dmac ,Sdmac ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,